Home / HEADLINES / First human trial to evaluate vaccine against COVID-19 begins in US

First human trial to evaluate vaccine against COVID-19 begins in US

The first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle, US health officials said.

The US National Institutes of Health (NIH) said in a statement that the open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccine yesterday.

Please share this news

Check Also

NYKS is one of the largest youth organizations in the world: Shri Kiren Rijiju

Ministry of Youth Affairs and Sports implements different youth centric activities for youth development through …